Top 10 Analyst Upgrades & Downgrades (ATK, CELG, NTAP, NVLS, WMT, ATHN, ARNA, BK, GENZ, Q)
September 21, 2009 by Douglas A. McIntyreThese are the top 10 analyst upgrades, downgrades, and initiations we have seen early this Monday morning:
Alliant Techsystems (ATK) Started as Buy at Jefferies.
Celgene (CELG) raised to Outperform at R.W.Baird.
NetApp (NTAP) raised to Conviction Buy List at Goldman Sachs
Novellus (NVLS) Raised to Outperform at Credit Suisse.
Wal-Mart (WMT) Started as Overweight at HSBC.
Athenahealth (ATHN) started as Sell at Citigroup.
Arena Pharmaceuticals (ARNA) cut to Market Perform at Leerink Swann.
Bank of New York Mellon (BK) Cut to Neutral at Goldman Sachs.
Genzyme (GENZ) Cut to Perform at Oppenheimer.
Qwest (Q) Cut to Conviction Sell List, but was already a Sell, at Goldman Sachs.
JON C. OGG
ALERT: Take This Retirement Quiz Now (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.